Hollywood actor Christina Applegate has reaffirmed her commitment to supporting the multiple sclerosis (MS) community after revealing that doctors told her she had been misdiagnosed with the condition.
Speaking on the October 27 episode of her MeSsy podcast, which she co-hosts with fellow actor Jamie-Lynn Sigler, Applegate assured listeners that she would continue advocating for people living with MS.
“I am still your warrior,” she said, reaffirming her support for the community despite the uncertainty surrounding her own diagnosis.
Misdiagnosis Leaves Actor Searching for Answers
Applegate revealed last week that doctors had told her she did not have multiple sclerosis, more than five years after receiving the diagnosis in 2021.
The news left the Dead to Me star feeling confused and distressed. She continues to experience serious symptoms and mobility difficulties but is now seeking another explanation for her condition.
Pakistan’s Business Leaders Criticise SBP Rate Hike to 12%
Applegate previously said the news made her feel as though she had let people down, particularly members of the MS community who had connected with her through her advocacy.
She remains grateful for the support she has received and acknowledged that the news may have left podcast listeners uncertain about what comes next. She plans to consult a rheumatologist and may seek advice from other specialists as she continues investigating her symptoms.
Jamie-Lynn Sigler Reassures Applegate
Sigler, who has multiple sclerosis herself, reassured her co-host that their podcast would continue.
She explained that MeSsy was never exclusively about MS but also explored their personal lives, experiences and the challenges they face.
The podcast has provided a platform for both actors to discuss difficult experiences openly and connect with listeners facing similar challenges.
Applegate Remains Committed to Advocacy
Applegate’s earlier diagnosis gave her a framework for understanding her symptoms and helped her connect with people living with MS. The reported misdiagnosis has now left her searching for a different explanation while continuing to navigate physical challenges.
Her experience also highlights the difficulties doctors can face when diagnosing multiple sclerosis. No single test can independently confirm every case, and MS symptoms can overlap with those of other neurological and autoimmune conditions.
Despite the uncertainty, Applegate says she intends to remain a voice for the MS community. Her message is that her commitment to supporting people living with the condition will continue while she seeks answers about her own health.
